FDA Inspection 1051099 — Optiscan Biomedical Corporation

Optiscan Biomedical Corporation — FEI 3010900725

The FDA completed an inspection of Optiscan Biomedical Corporation on May 7, 2018 in Hayward, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 7, 2018
Fiscal Year
2018
Product Type
Devices
Project Area
Compliance: Devices
Location
Hayward, CA (United States)

Citations

IDCFRDescription
312821 CFR 820.90(a)Nonconforming product control
313021 CFR 820.100(a)Lack of or inadequate procedures